Margaretta Nyilas is a biopharmaceutical executive with over twenty years of diverse, global industry experience (CNS, digital therapeutics, oncology, analgesia, anti-infective, pediatric, orphan disease, different formulation and drug-device combination development) with proven ability to deliver high value assets. Transformational change leader in pioneering innovative approaches in clinical and business operations delivering quality and timely execution of large scale, global clinical development portfolios from early stage development through lifecycle management. Recognized as a clinical trial innovator leading the industry’s first end-to-end e-Trial with digital health technology. Currently serving as a board member and executive advisor to biotech and health tech startups and supporting venture capital investments focusing on this space.